Monotherapy with High-Dose Once-Daily Tigecycline is Highly Effective Against Acinetobacter baumanii and other Multidrug-Resistant (MDR) Gram-Negative Bacilli (GNB)

Int J Antimicrob Agents. 2018 Jul;52(1):119-120. doi: 10.1016/j.ijantimicag.2018.02.011. Epub 2018 Mar 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acinetobacter*
  • Drug Resistance, Multiple, Bacterial
  • Gram-Negative Bacteria
  • Tigecycline*

Substances

  • Tigecycline